Reference
Clarke S, et al. Equity and Affordability: Reimbursement of Eculizumab in the Irish Health Care Setting. 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PSY91, 21 May 2016. Available from: URL: http://www.ispor.org/research_study_digest/list.asp?qs=44743
Rights and permissions
About this article
Cite this article
Eculizumab reimbursed in Ireland despite high costs. PharmacoEcon Outcomes News 755, 23 (2016). https://doi.org/10.1007/s40274-016-3130-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3130-1